| Ory Daniel Scott | EVP, Chief Medical Officer | 950,000Stock Option (right to buy) | $3.1M | Grant / award | |
|---|
| O'Neill Gilmore Neil | CEO | 5,124Common Stock | $16.2K | Sell | |
|---|
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | 709Common Stock | $2.2K | Sell | |
|---|
| Parison Amy | SVP, Chief Financial Officer | 453Common Stock | $1.4K | Sell | |
|---|
| Ellinor Patrick Thomas II | Director | 103,400Stock Option (right to buy) | $266.8K | Grant / award | |
|---|
| Parison Amy | SVP, Chief Financial Officer | 678Common Stock | $1.7K | Sell | |
|---|
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | 4,928Common Stock | $12.8K | Sell | |
|---|
| Levy Elliott M. | Director | 51,700Stock Option (right to buy) | $129.3K | Grant / award | |
|---|
| Scadden David | Director | 51,700Stock Option (right to buy) | $129.3K | Grant / award | |
|---|
| Hirsch Andrew | Director | 51,700Stock Option (right to buy) | $129.3K | Grant / award | |
|---|
